TY - JOUR
T1 - Características de los ensayos clínicos activos desarrollados en la Seguridad Social de Salud del Perú
AU - Soto-Ordoñez, Suly
AU - Herrera-Añazco, Percy
AU - Estrada-Martínez, Maggie
AU - Failoc-Rojas, Virgilio E.
N1 - Publisher Copyright:
© 2022 rcmhnaaa. All rights reserved.
PY - 2022/4
Y1 - 2022/4
N2 - Objetive: To describe the characteristics of active clinical trials (CTs) developed in the Social Health Security of Peru. Material and methods: Observational and descriptive study of active CTs between May 24 to July 8, 2021, registered in the Peruvian Registry of Clinical Trials during the period 2007-2020. The distribution of the different variable was analyzed, such as the number of CTs, phase, EsSalud networks, sponsor, funding sources, specialty, number of EsSalud research centers per CT, CIEI that approved CT by research center, and the calculation of relative and absolute frequencies. Results: 97 active CTs were identified, executed 144 times in 23 different research centers that belong to EsSalud. 94.9% of the active CTs were sponsored by pharmaceutical industries and 36% belong to the specialty of oncology. 80.42% are phase III and 70.8% were approved by an EsSalud CIEI. Conclusions: The active CTs in EsSalud are developed mostly in Lima, are financed by the pharmaceutical industry and are mostly approved in the CIEI of EsSalud.
AB - Objetive: To describe the characteristics of active clinical trials (CTs) developed in the Social Health Security of Peru. Material and methods: Observational and descriptive study of active CTs between May 24 to July 8, 2021, registered in the Peruvian Registry of Clinical Trials during the period 2007-2020. The distribution of the different variable was analyzed, such as the number of CTs, phase, EsSalud networks, sponsor, funding sources, specialty, number of EsSalud research centers per CT, CIEI that approved CT by research center, and the calculation of relative and absolute frequencies. Results: 97 active CTs were identified, executed 144 times in 23 different research centers that belong to EsSalud. 94.9% of the active CTs were sponsored by pharmaceutical industries and 36% belong to the specialty of oncology. 80.42% are phase III and 70.8% were approved by an EsSalud CIEI. Conclusions: The active CTs in EsSalud are developed mostly in Lima, are financed by the pharmaceutical industry and are mostly approved in the CIEI of EsSalud.
KW - Drogas en Investigación
KW - Ensayos Clínicos como Asunto
KW - Investigación
KW - Perú. (Source: DeCS-BIREME)
KW - Drogas en Investigación
KW - Ensayos Clínicos como Asunto
KW - Investigación
KW - Perú. (Source: DeCS-BIREME)
UR - http://www.scopus.com/inward/record.url?scp=85140218530&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/1f64694e-6b7b-3e2e-ad69-bae565ee9bd4/
U2 - 10.35434/rcmhnaaa.2022.152.1227
DO - 10.35434/rcmhnaaa.2022.152.1227
M3 - Artículo
AN - SCOPUS:85140218530
SN - 2225-5109
VL - 15
SP - 185
EP - 190
JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
IS - 2
ER -